NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

Research Triangle Park-based agribusiness Syngenta Biotechnology Inc. (SBI) is getting ready to plow down some of its property to rebuild for the future.

Software to bring hard data to global health will get the spotlight Thursday in a breakfast forum at the North Carolina Biotechnology Center.

Frederic Bost, director of information systems for Research Triangle Park drug discovery and development company SCYNEXIS will lead the discussion with local global health organizations and the general public.

Research Triangle Park pharmaceutical company Cognosci is celebrating its 10th anniversary with another winner in a string of good news.

The small biotech firm has received a $330,000 grant from the Accelerating Commercial Development program sponsored by Fast Forward (a division of the National Multiple Sclerosis Society) and EMD Serono, a division of Merck KGa.

Another in a string of North Carolina Biotechnology Center funding recipients is compounding the award with more cash and kudos.

Patrick Sullivan, M.D., of the University of North Carolina School of Medicine, landed a $126,400 Biotechnology Center grant four years ago to support his work developing high-speed techniques for parsing the genetic makeup of mammalian cells.

North Carolina will share its experiences and expertise in finance, international partnerships, devices, biologics and diagnostics Wednesday at the BIO 2010 International Convention.

The 10 speakers will participate in:

The Global Innovation Network - International Case Studies
3:00 PM S101B
John Chaffee, North Carolina Eastern Region

North Carolina women historically have more preterm births than the national average. And the state's infant mortality rate has also exceeded the American average.

Now, thanks to a $151,246 Institutional Development Grant from the North Carolina Biotechnology Center, an interdisciplinary team of Appalachian State University researchers is buying lab equipment to study the preterm birth situation.

Global agricultural giant Monsanto has signed a long-term lease to set up a research lab to study vegetable taste and nutrition at the North Carolina Research Campus in Kannapolis.

Monsanto, which already employs some 70 R&D people in Research Triangle Park and several more at a soy-breeding research station in Mount Olive, is the 18th company to set up shop at the growing Kannapolis facility.

The North Carolina Biotechnology Center has awarded a $30,000 low-interest Company Inception Loan to a young Asheville medical therapeutics company, Venafair.

Vascular surgeon Richard Bock, founder of the firm, said the loan is key for the company's plans for commercial development of vascular agents for treatment of varicose veins, usually in the legs.

PhaseBio Pharmaceuticals, an 8-year-old Morrisville drug-development firm whose start-up was supported by three loans from the North Carolina Biotechnology Center, has landed $25 million in new Series B venture funding.

A Catawba College student who won a $5,000 undergraduate research award from the North Carolina Biotechnology Center last year has added another major feather to his academic cap.

Nathaniel Griffin, a senior from the Wilkes County town of Boomer, N.C., who is pursuing a double major in chemistry and biology, has won the American Chemical Society's (ACS) 2010 Student Leadership Award.

Two young North Carolina bioscience-related companies are among the first 26 emerging technology firms chosen to give presentations to the Southeastern venture capital community next month.

The fourth annual Southeast Venture Conference, to be held February 24 and 25 at the Ritz Carlton in Tysons Corner, Virginia, will showcase some 60 promising technology firms from throughout the region. That's nearly twice the number participating in previous years.

North Carolina-based non-profit organizations can help their communities become biotech business beneficiaries.

How? By pursuing up to $75,000 in grant funding from the North Carolina Biotechnology Center's Regional Development Grant program.

But a January 27 deadline is fast approaching.

Bioscience companies throughout North Carolina can get reduced-price Internet access to science and business information, thanks to contract pricing arranged by the information specialists at the North Carolina Biotechnology Center library.

The service, especially useful to emerging companies around the state that have limited budgets, includes:

Pioneer Surgical Technology, which has a research facility in Greenville started with the help of $190,000 in funding from the North Carolina Biotechnology Center in 1995, has entered the Chinese market with its full range of spinal-fusion products.

Pioneer's Chinese partner, Bonovo Orthopedics, Inc., a manufacturer and distributor of orthopedic products, has received its government's approval to distribute Pioneer's full product line there.

It isn't because he's so successful at avoiding rivalries by holding concurrent professorships at the University of North Carolina at Chapel Hill and North Carolina State University.

Joseph DeSimone, Ph.D., is just plain successful.

scroll back to top of page